Introduction {#s1}
============

Ovulation is a complex process of releasing fertilizable oocytes from mature follicles and is essential for animal reproduction ([@bib11]). To ensure successful ovulation, a follicle must be developed to full maturity to be competent to receive an ovulatory stimulus and to activate proteolytic systems for follicle rupture. Several proteolytic systems have been found to regulate follicle rupture in vertebrates, including matrix metalloproteinase (Mmp), plasminogen activator/plasmin, and ADAMS-TS ([@bib5]; [@bib46]). In addition, a surge of luteinizing hormone (LH) serves as a master regulator to initiate the ovulation event and activates the EGF/EGFR-Ras-MAPK signaling pathway to propagate the ovulatory signal from outer granulosa cells to inner cumulus cells in the preovulatory follicles ([@bib4]; [@bib14], [@bib12], [@bib13]; [@bib16]). However, molecular mechanisms coupling the Ras-MAPK pathway to the activation of proteolytic systems for follicle rupture are largely unknown.

Ovulation in *Drosophila* utilizes conserved molecular mechanisms and involves a follicle rupture process to release mature oocytes from the ovary. *Drosophila* have two ovaries, connected at their posterior ends by bilateral oviducts ([Figure 1](#fig1){ref-type="fig"}). Each ovary contains \~16 ovarioles, where egg chambers are assembled in the germarium at the anterior and develop through 14 characteristic stages toward the posterior end ([@bib41]). Each egg chamber contains one oocyte and 15 nurse cells surrounded by a layer of somatic follicle cells. In stage-14 egg chambers (also named mature follicles), all nurse cells are degraded, leaving an oocyte surrounded by follicle cells; Matrix metalloproteinase 2 (Mmp2) is upregulated in posterior follicle cells ([Figure 1](#fig1){ref-type="fig"}; [@bib6]). In addition, *Oamb (octopamine receptor in mushroom body)*, encoding an α-adrenergic receptor-like G-protein-coupled receptor for octopamine (OA), is also upregulated in all follicle cells of stage-14 egg chambers ([@bib25]; [@bib7]). OA, released from terminal nerves that innervate ovaries, activates Oamb receptor in stage-14 follicle cells, which induces calcium rise and activates Mmp2 ([@bib7]; [@bib15]; [@bib27]; [@bib29]). Mmp2 enzymatic activity leads to degradation of posterior follicle cells and release of the encapsulated oocyte (called follicle rupture; [Figure 1](#fig1){ref-type="fig"}; [@bib6]). The rest of the follicle cells remain at the end of the ovariole to form a corpus luteum ([@bib6]). Local adrenergic signaling has also been suggested to regulate mammalian ovulation but no molecular mechanisms have been illustrated ([@bib18]; [@bib40]). In parallel to progesterone signaling in mammalian ovulation, ecdysteroid signaling is also activated in stage-14 follicle cells and is essential for *Drosophila* ovulation; ecdysteroid signaling modulates OA/Oamb-induced Mmp2 activation, but does not affect Oamb expression nor Mmp2 expression ([@bib22]). Thus, it is currently unknown what induces Mmp2 and Oamb expression in stage-14 follicle cells and how these follicles become fully competent for ovulation.

![An illustration of *Drosophila* ovulation process.\
The female reproductive system, consisting of two ovaries, oviduct, uterus, seminal receptacle, and a pair of spermathecae and parovaria, was depicted in the cartoon. Two representative ovarioles with different staged egg chambers were highlighted in the right ovary. Oocytes and nurse cells are in yellow. Mmp2 expression is shown in green and Mmp2 activity is shown in red.](elife-29887-fig1){#fig1}

The zinc-finger transcription factor Hindsight (Hnt; encoded by gene *pebbled*) contains 14 C2H2 zinc-finger domains and is homologous to mammalian Ras-responsive element-binding protein 1 (RREB-1). Both Hnt and RREB-1 bind to similar DNA sequences, and human RREB-1 can functionally replace Hnt in attenuating expression of *nervy* and *hnt* itself in *Drosophila* salivary gland ([@bib28]). RREB-1 functions downstream of the Ras-MAPK pathway to either suppress or promote Ras target genes in multiple tissues including colon, thyroid, and pancreatic cancers ([@bib19], [@bib20]; [@bib30]; [@bib47]; [@bib54]). Hnt is expressed in a variety of tissues in development and plays multiple developmental roles including control of embryonic germ band retraction ([@bib53]; [@bib39]), regulation of retinal cell fate and morphogenesis ([@bib36]; [@bib51]; [@bib37]; [@bib32]; [@bib31]), maintenance of tracheal epithelial integrity ([@bib52], [@bib51]), and differentiation of spermathecae and intestinal stem cells ([@bib45]; [@bib2]). Hnt is also expressed in follicle cells of stage 7-10A egg chambers, where it functions as a downstream target of Notch signaling to suppress Hedgehog signaling and to induce the mitotic/endocycle transition ([@bib44]). Hnt continues its expression in anterior follicle cells throughout late oogenesis. In contrast, Hnt expression in mainbody follicle cells is downregulated from stage 10B to stage 13 and re-upregulated in stage-14 ([@bib6]), where its role is unknown. Moreover, few downstream targets of Hnt have been identified and its relationship to Ras signaling is also unknown.

Here, we characterized the dynamic expression of Hnt in stage-14 follicle cells. By using molecular and genetic tools, we demonstrated that Hnt expression in stage-14 follicle cells is essential for follicle rupture partly by upregulation of Oamb and Mmp2 expression in these follicle cells. Thus, Hnt functions as an essential transcription factor to prime follicles to be competent for follicle rupture/ovulation. In addition, Hnt's role in follicle rupture can be replaced by human RREB-1. Our data, along with the involvement of Ras-MAPK signaling in mammalian ovulation, lead us to propose that Hnt/RREB-1 has a conserved role in regulating follicle rupture/ovulation downstream of Ras-MAPK signaling pathway.

Results {#s2}
=======

Dynamic expression of Hindsight in stage-14 follicle cells {#s2-1}
----------------------------------------------------------

Hnt is not expressed in stage-13 follicle cells except those at the anterior region; however, it is upregulated in all stage-14 follicle cells and the corpus luteum ([@bib6]). Upon closer examination, we found three distinct patterns of Hnt expression throughout stage-14 egg chambers: (I) high Hnt expression in anterior and posterior but low/no Hnt in the middle follicle cells ('A/P-Hnt' egg chambers; [Figure 2A and F](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A--B](#fig2s1){ref-type="fig"}); (II) high Hnt expression in all follicle cells ('high-Hnt' egg chambers; [Figure 2B and G](#fig2){ref-type="fig"}); (III) low Hnt expression in all follicle cells ('low-Hnt' egg chambers; [Figure 2C and H](#fig2){ref-type="fig"}; also see [Figure 2---figure supplement 1C--D](#fig2s1){ref-type="fig"}). To determine the developmental sequence of the aforementioned three types of stage-14 egg chambers, we analyzed the expression patterns of Hnt against the expression of a stage-14 follicle-cell Gal4 driver (44E10-Gal4; renamed as FC1 for simplicity) ([@bib7]) and the number of nurse cell nuclei in these egg chambers. 86% of A/P-Hnt egg chambers had medium-level GFP expression driven by FC1, while more than 73% of high-Hnt and 80% of low-Hnt egg chambers had high-level GFP expression ([Figure 2A--D](#fig2){ref-type="fig"}). This indicates that A/P-Hnt egg chambers are the youngest, which is consistent with the observation that A/P-Hnt egg chambers typically have more residual nurse-cell nuclei than the other two types of egg chambers ([Figure 2E](#fig2){ref-type="fig"}). In addition, high-Hnt egg chambers still contained one or two nurse-cell nuclei, while low-Hnt egg chambers typically did not contain nurse-cell nuclei and were skinner and dehydrated ([Figure 2E](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}). Because nurse-cell nuclei are progressively degraded starting around stage-12 by a non-cell-autonomous mechanism to generate fully matured egg chambers, which have no nurse cell nuclei and are dehydrated ([@bib8]; [@bib48]), the above analysis demonstrates that high-Hnt egg chambers are at the intermediate stage, while low-Hnt egg chambers are the most mature egg chambers.

![Hindsight expression in stage-14 egg chambers.\
(**A--C**) Hnt expression (red in A-C and white in A'-C') in A/P-Hnt (**A**), high-Hnt (**B**), and low-Hnt (**C**) egg chambers. FC1 expression (FC1 Gal4 driving *UAS-eGFP*, *FC1 \> GFP*) is shown in green (**A--C**) and white in (**A"--C"**). Nuclei are shown by DAPI in blue (**A--C**). (**D--E**) Quantification of FC1 expression (**D**) and residual nurse cell nuclei (**E**) in A/P-Hnt, high-Hnt, and low-Hnt egg chambers. The number of stage-14 egg chambers analyzed is noted above each bar. (**F--H**) Hnt expression (red in F-H and white in F'-H') in A/P-Hnt (**F**), high-Hnt (**G**), and low-Hnt (**H**) egg chambers. FC2 expression (*FC2 \> GFP*) is shown in green (**F--H**) and white (**F"--H"**). Nuclei are shown in blue (**F--H**). (**I--J**) Quantification of FC2 expression (**I**) and residual nurse cell nuclei (**J**) in A/P-Hnt, high-Hnt, and low-Hnt egg chambers. (**K**) A schematic cartoon shows the temporal pattern of Hnt, FC1 and FC2 expression in stage-14 egg chambers. FC1-related graphs are colored green and FC2-relaed graphs are colored blue.](elife-29887-fig2){#fig2}

This conclusion was further supported by additional analysis using a late stage-14 follicle-cell Gal4 driver (47A04-Gal4; renamed as FC2 for simplicity) ([@bib7]). Consistent with the previous result, both A/P- and high-Hnt egg chambers had no or minimal GFP expression driven by FC2, while low-Hnt egg chambers had highest GFP expression and fewest nurse-cell nuclei ([Figure 2F--J](#fig2){ref-type="fig"}). Altogether, these analyses demonstrate that Hnt is first upregulated in posterior follicle cells, filled in across the entire egg chamber, and then overall downregulated in follicle cells of fully matured egg chambers ([Figure 2K](#fig2){ref-type="fig"}). Therefore, we propose to categorize stage-14 egg chambers into three distinct stages and rename A/P-, high-, and low-Hnt egg chambers as stage-14A, stage-14B, and stage-14C egg chambers, respectively ([Figure 2K](#fig2){ref-type="fig"}).

Hindsight in stage-14 follicle cells is required for normal ovulation {#s2-2}
---------------------------------------------------------------------

The dynamic Hnt expression in stage-14 follicle cells prompted us to investigate its function in follicle maturation and ovulation. To bypass the early requirement of Hnt in follicle cell differentiation ([@bib44]), we used RNA interference (RNAi) to deplete Hnt expression specifically in stage-14 follicle cells with FC1 or FC2 Gal4 driving *UAS-hnt^RNAi^* expression. While FC1 started to be expressed in stage-14A follicle cells, it was weak to deplete Hnt expression in stage-14A follicle cells ([Figure 3---figure supplement 1A--D](#fig3s1){ref-type="fig"}), but became progressively more efficient in older follicle cells with two independent *hnt^RNAi^* lines ([Figure 3A--D](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1E--H](#fig3s1){ref-type="fig"}); more than 80% of stage-14C egg chambers had no detectable Hnt expression in their follicle cells. In contrast, FC2 started to be expressed in stage-14B follicle cells and most effectively depleted Hnt expression in stage-14C follicle cells except with *hnt^RNAi2^*, which only showed strong reduction in \~43% of egg chambers ([Figure 3E--H](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1I--P](#fig3s1){ref-type="fig"}).

![Hindsight expression in stage-14 follicle cells is essential for normal ovulation.\
(**A--D**) Hnt expression (green) in control (**A**) and *hnt^RNAi^* (**B--C**) stage-14C egg chambers with FC1. FC1 expression (*FC1 \> RFP*) is shown in red. Inserts are high magnification of Hnt expression in squared areas. The quantification of Hnt expression (categorized as high-Hnt, low-Hnt, A/P-Hnt, and None-Hnt) in stage-14C egg chambers is shown in (**D**). The number of stage-14C egg chambers (selected according to no nurse-cell nuclei/high FC1 expression) analyzed is noted above each bar. (**E--H**) Hnt expression (green) in control (**E**) and *hnt^RNAi^* (**F--G**) stage-14C egg chambers with FC2. FC2 expression (*FC2 \> RFP*) is shown in red. Inserts are high magnification of Hnt expression in squared areas. The quantification of Hnt expression in stage-14C egg chambers is shown in (**H**). The stage-14C egg chambers are selected according to no nurse-cell nuclei/high FC2 expression. (**I--J**) The quantification of egg laying (**I**) and mature egg chambers in each female's ovaries after egg laying (**J**) in control or *hnt^RNAi^* females with FC1 (green bars) or FC2 Gal4 (blue bars). The number of females is noted above each bar. (**K--L**) The egg-laying time in control or *hnt^RNAi^* females with FC1 (**K**) or FC2 (**L**). Also see [Supplementary file 1](#supp1){ref-type="supplementary-material"}. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](elife-29887-fig3){#fig3}

Females with RNAi-mediated *hnt* depletion in stage-14 follicle cells (named *hnt^RNAi^* females for simplicity) were then assayed for egg-laying ability. *hnt^RNAi^* females laid significantly fewer eggs than control females after mating ([Figure 3I](#fig3){ref-type="fig"}). This phenotype was manifested by using both stage-14 follicle-cell Gal4 drivers and with two independent *hnt^RNAi^* lines, which demonstrates that Hnt expression in stage-14 follicle cells was essential for normal egg laying. The decrease in egg-laying number was not caused by an oogenesis defect, as plenty of stage-14 egg chambers were observed before and after egg-laying experiments ([Figure 3J](#fig3){ref-type="fig"} and [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). The egg-laying process consists of ovulation (the release of egg from the ovary into the oviduct), egg transportation through the oviduct, and oviposition (the release of egg in the uterus to the outside environment). To determine which step in the egg-laying process was affected in *hnt^RNAi^* females, we utilized our previously developed method to estimate the average time required for each step in the egg-laying process ([@bib45]; [@bib7]; [@bib22]). Consistent with our previous data, control females spent 12--14 min to ovulate an egg, less than a minute to transport egg through the oviduct, and eight - 10 min to hold an egg in the uterus and oviposit ([Figure 3K--L](#fig3){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). In contrast, *hnt^RNAi^* females spent more than 25 min to ovulate an egg, which was significantly longer than the control females ([Figure 3K--L](#fig3){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). These data demonstrate that Hnt in stage-14 follicle cells is required for normal ovulation.

Hindsight in stage-14 follicle cells is necessary for OA-induced follicle rupture {#s2-3}
---------------------------------------------------------------------------------

Ovulation consists of a breakdown of posterior follicle cells and a subsequent rupture of oocyte into the lateral oviduct ([Figure 1](#fig1){ref-type="fig"}), which is induced by octopaminergic signaling and can be recapitulated in an *ex vivo* culture system ([@bib7]). The requirement of Hnt for normal ovulation led us to hypothesize that Hnt is required for OA-induced follicle rupture. Consistent with this idea, about 45% stage-14 egg chambers isolated according to FC1 expression from control females ruptured in response to OA stimulation, whereas fewer than 10% of egg chambers from *hnt^RNAi^* females ruptured in response to OA stimulation ([Figure 4A--D](#fig4){ref-type="fig"}). In addition, more than 85% stage-14 egg chambers isolated according to FC2 expression from control females ruptured in response to OA stimulation ([Figure 4E and H](#fig4){ref-type="fig"}), consistent with the fact that FC2 is expressed in more mature egg chambers than FC1 ([Figure 2](#fig2){ref-type="fig"}). In contrast, egg chambers isolated from *hnt^RNAi1^* or *hnt^RNAi2^* females with FC2 ruptured at the rate of 10% and 33%, respectively ([Figure 4F--H](#fig4){ref-type="fig"}). Consistent with this result, follicles isolated from *hnt* transheterozygous mutant females also showed significant reduction in OA-induced follicle rupture in comparison to control follicles ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These results demonstrate that Hnt is required in stage-14 follicle cells for follicle rupture.

![Hindsight is required for OA-induced follicle rupture.\
(**A--D**) Representative images show control (**A**) and *hnt^RNAi^* (**B--C**) egg chambers with FC1 after three-hour culture with 20 μM OA. Quantification of OA-induced follicle rupture is shown in (**D**). (**E--H**) Representative images show control (**E**) and *hnt^RNAi^* (**F--G**) egg chambers with FC2 after three-hour culture with 20 μM OA. Quantification is shown in (**H**). Egg chambers were isolated according to *FC1 \> RFP* (red in A-C) or *FC2 \> RFP* (red in E-G) expression. Bright-field images of the egg chambers are shown in blue, and ruptured egg chambers are marked by white arrowheads. The number of egg chambers is listed above each bar. \*\*\*p\<0.001.](elife-29887-fig4){#fig4}

Hindsight is essential for Mmp2 activity in posterior follicle cells of stage-14 egg chambers {#s2-4}
---------------------------------------------------------------------------------------------

Mmp2 is essential for follicle rupture, and its enzymatic activity is activated by OA stimulation ([@bib7]). To determine whether Hnt regulates follicle rupture by influencing Mmp2 activity, we assayed Mmp2 enzymatic activity in egg chambers from control and *hnt^RNAi^* females after OA stimulation *ex vivo*. After a three-hour incubation with OA, \~60% of control egg chambers isolated according to FC1 expression had posterior gelatinase activity ([Figure 5A and D](#fig5){ref-type="fig"}), whereas only \~25% of *hnt^RNAi^* egg chambers had posterior gelatinase activity ([Figure 5B--D](#fig5){ref-type="fig"}). In addition, about 90% of control egg chambers isolated according to FC2 had posterior gelatinase activity, in contrast to 25% and 47% of *hnt^RNAi1^* and *hnt^RNAi2^* egg chambers, respectively ([Figure 5E--H](#fig5){ref-type="fig"}). The proportion of follicles with posterior gelatinase activity was correlated to the proportion of follicles that ruptured, and both were significantly decreased in *hnt^RNAi^* egg chambers, which strongly supports that Hnt controls follicle rupture by regulating Mmp2 activity.

![Hindsight regulates Mmp2 activity in stage-14 follicle cells.\
(**A--C**) Representative images show OA-induced Mmp2 activity (green) in control (**A**) and *hnt^RNAi^* (**B--C**) egg chambers with FC1 after three-hour culture with OA. Egg chambers with posterior Mmp2 activity are marked by arrowheads. Quantification is shown in (**D**). (**E--H**) Representative images show OA-induced Mmp2 activity (green) in control (**E**) and *hnt^RNAi^* (**F--G**) egg chambers with FC2 after three-hour culture with OA. The quantification is shown in (**H**). (**I**) A diagram shows the three categories of basement-membrane (BM) configurations (according to Vkg::GFP expression) of follicle cells in isolated stage-14 egg chambers. When a line connecting the posterior-most Vkg edges bisects the oocyte, it is defined as an open-BM configuration, whereas when the line does not bisect the oocyte, it is defined as a broken-BM configuration. The intact-BM configuration is defined as intact, continuous Vkg::GFP throughout the posterior of the egg chamber. (**J--J\'**) A control egg chamber identified according to FC2 \>RFP expression shows the open-BM configuration. (**K--K'**) An egg chamber with overexpression of *Timp* shows the intact-BM configuration. (**L--L'**) An *Mmp2^RNAi^* egg chamber shows the broken-BM configuration. (**M--N**) *hnt^RNAi^* egg chambers show intact-BM (**M--M'**) and broken-BM (**N--N'**) configurations. (**O**) Quantification of BM configurations of FC2-expressing egg chambers with respective genotypes. The number of egg chambers analyzed is noted above each bar. \*\*\*p\<0.001.](elife-29887-fig5){#fig5}

To further support this notion and to avoid the possibility that the above observed phenomenon is an artifact of *ex vivo* culture, we determined whether Hnt indeed regulates Mmp2 activity *in vivo*. One of the known substrates of Mmp2 is the basement-membrane (BM) protein collagen IV, encoded by *viking* (*vkg*), during imaginal disc morphogenesis and fatbody dissociation at pupal development ([@bib42]; [@bib17]). Vkg is detected in the basement membrane of follicle cells throughout oogenesis and we reasoned it could be a substrate of follicular Mmp2 as well. We found that 70% of FC2-expressing egg chambers had lost follicular Vkg protein in a large posterior area (open-BM configuration), 26% had lost Vkg protein in a small posterior area (broken-BM configuration), and 4% had intact Vkg protein (intact-BM configuration) at their posterior end ([Figure 5I--J and O](#fig5){ref-type="fig"}). When *tissue inhibitor of matrix metalloproteinase* (*Timp*, encoding an inhibitor of Mmp enzymatic activity) was overexpressed in stage-14 follicle cells using FC2, the BM configuration was dramatically shifted toward intact-BM configuration ([Figure 5K and O](#fig5){ref-type="fig"}), indicating that Mmp activity is responsible for the degradation of Vkg at the posterior end of stage-14 egg chambers. In addition, RNAi-mediated *Mmp2* depletion in stage-14 follicle cells showed a similar trend as overexpression of *Timp*, although less effectively ([Figure 5L and O](#fig5){ref-type="fig"}), demonstrating that Mmp2 is, at least partially, responsible for the Vkg degradation. Furthermore, *hnt* depletion in stage-14 follicle cells also shifted BM configuration toward broken- and intact-BM configuration as *Mmp2* depletion ([Figure 5M--O](#fig5){ref-type="fig"}). Altogether, these data demonstrate that Hnt regulates Mmp2 activity, which is responsible for Vkg degradation at the posterior end of stage-14 egg chambers during ovulation.

Hindsight is required for Mmp2 expression in posterior follicle cells at stage 14 {#s2-5}
---------------------------------------------------------------------------------

OA binds to Oamb receptor in stage-14 follicle cells, which leads to a rise of intracellular Ca^2+^ concentration and subsequent activation of Mmp2 ([@bib7]). To elucidate the mechanism of Hnt in regulating Mmp2 activity, we sought to determine whether Hnt interferes with OA/Oamb-Ca^2+^-Mmp2 pathway upstream and/or downstream of Ca^2+^ rise. In comparison to OA, Ca^2+^ ionophore ionomycin was sufficient to induce more than 95% control egg chambers to rupture at the end of a three-hour culture, regardless whether egg chambers were isolated according to FC1 or FC2 expression ([Figure 6A,D,E and H](#fig6){ref-type="fig"}). In contrast, ionomycin was still not sufficient to induce follicle rupture in *hnt^RNAi^* egg chambers (except those with FC2 driving *hnt^RNAi2^* expression; [Figure 6B--D and F--H](#fig6){ref-type="fig"}), despite that it was able to induce Ca^2+^ rise in follicle cells ([Figure 6---figure supplement 1A--D](#fig6s1){ref-type="fig"}, [Videos 1](#video1){ref-type="video"}--[3](#video3){ref-type="video"}). The incompetency of *hnt^RNAi^* egg chambers to ionomycin stimulation indicates that Hnt regulates components downstream of Ca^2+^ rise in the OA/Oamb-Ca^2+^-Mmp2 pathway; the almost normal response to ionomycin but defective response to OA in *hnt^RNAi2^* egg chambers with FC2 indicates that Hnt also regulates components upstream of Ca^2+^ rise in the OA/Oamb-Ca^2+^-Mmp2 pathway. Consistent with this idea, OA was not sufficient to induce Ca^2+^ rise in *hnt^RNAi^* egg chambers with FC2 ([Figure 6---figure supplement 1E--H](#fig6s1){ref-type="fig"}, [Videos 4](#video4){ref-type="video"}--[6](#video6){ref-type="video"}). Since Hnt is first upregulated in posterior follicle cells ([Figure 2](#fig2){ref-type="fig"}), where Mmp2 is expressed ([@bib6]), and then swept across the entire follicle cells ([Figure 2](#fig2){ref-type="fig"}), where Oamb is expressed ([@bib25]; [@bib7]), we hypothesize that Hnt regulates both Mmp2 and Oamb expression in stage-14 follicle cells.

![Hindsight regulates Mmp2 expression in stage-14 follicle cells.\
(**A--H**) Response of egg chambers isolated according to FC1 (**A--D**) or FC2 (**E--H**) to ionomycin-induced rupture in three hours. (**A--C and E--G**) Representative images show control (**A and E**) and *hnt^RNAi^* (**B--C and F--G**) egg chambers after the culture. Bright field images of the egg chambers are shown in blue, and white arrowheads mark ruptured egg chambers. Quantification of rupture response to OA or to ionomycin is shown in (**D and H**). (**I--K**) Representative images show Mmp2::GFP expression (green in I-K and white in I'-K') in control (**I--I'**) or *hnt^RNAi^* (**J--K'**) egg chambers with FC2 Gal4 (Red). Nuclei are labeled with DAPI and shown in blue (**I--K**). Arrowheads point to posterior follicle cells, and oocytes are outlined in cyan (**I'--K'**). (**L--M**) Quantification of Mmp2::GFP expression in control and *hnt^RNAi^* egg chambers using FC1 (**L**) or FC2 (**M**) Gal4. (**N--O**) Quantification of *Mmp2* mRNA levels in *hnt^RNAi^* egg chambers with FC1 (**N**) or FC2 (**O**) Gal4. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](elife-29887-fig6){#fig6}

###### Signal of GCaMP5G driven by FC2 in Control follicles with ionomycin stimulation (*FC2 \> GCaMP5G*).

10.7554/eLife.29887.015

###### Signal of GCaMP5G driven by FC2 in *hnt^RNAi1^* follicles with ionomycin stimulation (*FC2 \> GCaMP5G/hnt^RNAi1^*).

10.7554/eLife.29887.016

###### Signal of GCaMP5G driven by FC2 in *hnt^RNAi2^* follicles with ionomycin stimulation (*FC2 \> GCaMP5G/hnt^RNAi2^*).

10.7554/eLife.29887.017

###### Signal of GCaMP5G driven by FC2 in Control follicles with octopamine stimulation (*FC2 \> GCaMP5G*).

10.7554/eLife.29887.018

###### Signal of GCaMP5G driven by FC2 in *hnt^RNAi1^* follicles with octopamine stimulation (*FC2 \> GCaMP5G/hnt^RNAi1^*).

10.7554/eLife.29887.019

###### Signal of GCaMP5G driven by FC2 in *hnt^RNAi2^* follicles with octopamine stimulation (*FC2 \> GCaMP5G/hnt^RNAi2^*).

10.7554/eLife.29887.020

To investigate the role of Hnt in Mmp2 expression, we examined Mmp2 expression using a *Mmp2::GFP* fusion gene in the endogenous locus. Consistent with our previous report, Mmp2::GFP was detected in posterior follicle cells of stage-14 egg chambers, most prominently in stage14B and 14C ([Figure 6I](#fig6){ref-type="fig"} and [Figure 6---figure supplement 2A](#fig6s2){ref-type="fig"}). Mmp2::GFP formed a gradient that peaked at the posterior tip and gradually decreased toward the anterior. In contrast, there was marked reduction of Mmp2::GFP intensity in *hnt^RNAi^* egg chambers ([Figure 6J--K](#fig6){ref-type="fig"} and [Figure 6---figure supplement 2B--C](#fig6s2){ref-type="fig"}). More than 80% of FC1- or FC2-expressing control egg chambers had moderate or high-level of Mmp2::GFP expression in their posterior follicle cells, while fewer than 30% of *hnt^RNAi^* egg chambers (32% in the case of FC2 driving *hnt^RNAi2^*) had moderate or high-level of Mmp2::GFP expression ([Figure 6L--M](#fig6){ref-type="fig"}). Due to technical challenges, we were unable to quantify Mmp2 protein level directly using western blotting. However, we speculated that Hnt might regulate *Mmp2* transcription. Therefore, we used real-time RT-PCR to quantify *Mmp2* mRNA level in control and *hnt^RNAi^* egg chambers. Consistent with this hypothesis, *Mmp2* mRNA levels were significantly decreased in *hnt^RNAi^* egg chambers in comparison to the control ([Figure 6N--O](#fig6){ref-type="fig"}). Altogether, these data demonstrate that Hnt regulates Mmp2 expression at the transcriptional level.

Hindsight is required for *Oamb* expression in stage-14 follicle cells {#s2-6}
----------------------------------------------------------------------

We noticed that *hnt^RNAi2^* egg chambers with FC2 Gal4 had slightly weaker reduction of *Mmp2* mRNA and protein expression ([Figure 6M and O](#fig6){ref-type="fig"}) and responded normally to ionomycin stimulation ([Figure 6H](#fig6){ref-type="fig"}), but were defective in OA-induced Ca^2+^ rise, Mmp2 activation, and follicle rupture ([Figures 4H](#fig4){ref-type="fig"} and [5H](#fig5){ref-type="fig"}, and [Figure 6---figure supplement 1E--H](#fig6s1){ref-type="fig"}). This suggests that components upstream of Ca^2+^ rise, for example Oamb, are defective in these egg chambers. Consistent with this hypothesis, *Oamb* mRNA was reduced two or more fold in *hnt^RNAi^* egg chambers regardless the Gal4 drivers or *hnt^RNAi^* lines ([Figure 7A--B](#fig7){ref-type="fig"}). Therefore, Hnt is also required for *Oamb* expression in stage-14 follicle cells.

![Hnt regulates *Oamb* expression in stage-14 follicle cells.\
(**A--B**) Quantification of *Oamb* mRNA levels in *hnt^RNAi^* egg chambers with FC1 (**A**) or FC2 (**B**) Gal4. (**C--D**) Quantification of egg chambers in response to OA-induced follicle rupture. *hnt^RNAi^* and/or *Oamb* overexpression is driven by FC1 (**C**) or FC2 (**D**) Gal4. (**E--L**) Representative images of the quantification in (**C--D**). FC1 \>RFP (**E--H**) or FC2 \>RFP (**I--L**) is shown in red, bright-field images of the egg chambers are shown in blue, and ruptured egg chambers are marked by white arrowheads. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](elife-29887-fig7){#fig7}

Next, we aimed to rescue the rupture defect of *hnt^RNAi^* egg chambers by overexpression of *Oamb. Oamb* overexpression was not able to restore the competency to OA-induced rupture in *hnt^RNAi^* egg chambers with FC1 or *hnt^RNAi1^* egg chambers with FC2, but it was able to do so in *hnt^RNAi2^* egg chambers with FC2 ([Figure 7C--D](#fig7){ref-type="fig"}), consistent with the ionomycin experiment ([Figure 6D and H](#fig6){ref-type="fig"}). These data suggest that the major defect in *hnt^RNAi2^* egg chambers with FC2 is the disruption of *Oamb* expression, while *hnt^RNAi1^* egg chambers with FC2 or *hnt^RNAi^* egg chambers with FC1 have more defects than Oamb alone, such as Mmp2 expression. The combination of later FC2 and weaker *hnt^RNAi2^* may explain why only Oamb is majorly affected in this genetic manipulation. In addition, we noticed that egg chambers with *Oamb* overexpression alone initiated rupture before being able to perform the *ex vivo* culture (i.e. few intact egg chambers could be isolated). This is likely due to its high Oamb expression, which leads to high sensitivity to very low amount of endogenous OA released during egg chamber isolation. Nevertheless, all these data support the notion that Hnt transcriptionally upregulates Mmp2 expression in posterior follicle cells and then Oamb expression in all follicle cells to make stage-14 egg chambers to be competent to respond to OA-induced follicle rupture.

Human RREB-1 can replace Hindsight's role in regulating follicle's competency to ovulation {#s2-7}
------------------------------------------------------------------------------------------

To address whether the role of Hnt in stage-14 follicle cells can be replaced by its human homolog RREB-1, we first aimed to rescue the defects of *hnt^RNAi^* egg chambers with *hnt* overexpression using *hnt^EP55^* (see Materials and methods). To our surprise, overexpression of *hnt* in *hnt^RNAi^* egg chambers did not rescue their defect in OA-induced follicle rupture ([Figure 8---figure supplement 1A and C](#fig8s1){ref-type="fig"}). In addition, these females laid similar numbers of eggs as *hnt^RNAi^* females ([Figure 8---figure supplement 1B and D](#fig8s1){ref-type="fig"}). Surprisingly, Hnt protein was still depleted despite using FC1 or FC2 Gal4 driving *hnt^EP55^* expression ([Figure 8---figure supplement 1E--L](#fig8s1){ref-type="fig"}), indicating that *hnt^RNAi^* is sufficient to disrupt overexpressed *hnt* mRNA. This was further validated in a flip-out Gal4 system, in which Hnt protein was greatly reduced in cells with both *hnt^RNAi^* and *hnt^EP55^* ([Figure 8---figure supplement 1M--P](#fig8s1){ref-type="fig"}). Despite the failure to rescue ovulation in *hnt*-depleted females, it is interesting to note that overexpression of *hnt* alone with FC1 or FC2 Gal4 driver enhanced and suppressed OA-induced follicle rupture, respectively ([Figure 8---figure supplement 1A and C](#fig8s1){ref-type="fig"}), suggesting that dynamic upregulation and downregulation of Hnt in stage-14 follicle cells may be required for normal function of these cells.

Next, a functional *RREB-1::GFP* fusion gene was overexpressed in *hnt^RNAi^* females with FC1 to see whether RREB-1 could rescue the ovulation defect of *hnt^RNAi^* females. *RREB-1* is successfully overexpressed in *hnt^RNAi^* egg chambers, and overexpression of RREB-1 did not affect Hnt expression in control nor *hnt^RNAi^* egg chambers ([Figure 8---figure supplement 2A--F](#fig8s2){ref-type="fig"}). *hnt^RNAi2^*/*RREB-1::GFP* females showed significant increase of egg-laying number in comparison to *hnt^RNAi2^ females*, indicating a rescue of ovulation defect ([Figure 8A](#fig8){ref-type="fig"}). This is supported by the result that *hnt^RNAi2^*/*RREB-1::GFP* females spent 13 min, in comparison to 27 min in *hnt^RNAi2^* females, to ovulate an egg, close to that in control females ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). In contrast, females with *hnt^RNAi1^*/*RREB-1::GFP* laid significantly fewer eggs than females with *hnt^RNAi1^* alone ([Figure 8A](#fig8){ref-type="fig"}) and spent even longer time to ovulate an egg ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). In addition, we noticed that these females frequently have eggs in the oviduct ([Supplementary file 1](#supp1){ref-type="supplementary-material"}), which may be caused by more frequent and uncoordinated follicle rupture leading to egg jamming in the oviduct. The persistence of egg in the oviduct may feedback to the ovary to inhibit further ovulation *in vivo*.

![Human RREB-1 can replace Hindsight's role in regulating follicle's competency to ovulation.\
(**A**) The quantification of egg-laying capacity of females with FC1 driving *hnt^RNAi^* and/or *RREB-1* overexpression. (**B--F**) The quantification of OA-induced follicle rupture (**B**) in egg chambers with *hnt^RNAi^* and/or *RREB-1* overexpression using FC1 Gal4. Representative images are shown in (**C--F**). FC1 \>RFP is shown in red, bright-field images of egg chambers are shown in blue, and white arrowheads mark ruptured follicles. (**G--H**) Quantification of *Oamb* (**G**) and *Mmp2* (**H**) mRNA level in egg chambers with FC1 Gal4 driving *hnt^RNAi^* and/or *RREB-1* overexpression. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.](elife-29887-fig8){#fig8}

To more directly investigate the role of RREB-1 in ovulation, we isolated stage-14 egg chambers and performed OA-induced follicle rupture *ex vivo*. Excitingly, *RREB-1::GFP* overexpression was sufficient to rescue the rupture defect of *hnt^RNAi^* egg chambers ([Figure 8B--F](#fig8){ref-type="fig"}), whereas overexpression of *UAS-GFP* was insufficient ([Figure 8---figure supplement 3](#fig8s3){ref-type="fig"}). In addition, overexpression of *RREB-1* alone led to increased OA-induced follicle rupture, similar to overexpression of *hnt* with FC1 ([Figure 8B](#fig8){ref-type="fig"} and [Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}). Consistent with the rescue of follicle rupture, both *Mmp2* and *Oamb* mRNA expression was rescued to normal or even higher level by overexpression of *RREB-1* ([Figure 8G--H](#fig8){ref-type="fig"}). Therefore, RREB-1 can replace Hnt's role in upregulating Mmp2 and Oamb expression in follicle cells. Altogether, our data demonstrate that zinc-finger transcription factor Hnt/RREB-1 may play conserved roles in promoting follicle maturation and ovulation competency.

Discussion {#s3}
==========

Hindsight regulates ovulation competency in stage-14 egg chambers {#s3-1}
-----------------------------------------------------------------

Work in this study demonstrated for the first time that Hnt has a dynamic expression pattern in stage-14 follicle cells and is a key factor for the final maturation of stage-14 egg chambers ([Figure 9](#fig9){ref-type="fig"}). Oocyte maturation has been well studied in *Drosophila* and other species ([@bib10]; [@bib23]; [@bib50]); however, the maturation of follicle cells surrounding the oocyte in the stage-14 egg chamber is poorly defined at the molecular level ([@bib9]; [@bib21]; [@bib41]). According to Hnt expression in stage-14 egg chambers, we define the stage-14 egg chambers into three sub stages. Hnt is first upregulated in posterior follicle cells of stage-14A egg chambers, which is likely corresponding to Hnt's role in upregulating Mmp2 expression in these follicle cells ([Figure 9](#fig9){ref-type="fig"}). Then Hnt is upregulated in all main-body follicle cells of stage-14B egg chambers, which is likely corresponding to Hnt's role in upregulating *Oamb* expression ([Figure 9](#fig9){ref-type="fig"}). The sequential upregulation of Mmp2 and Oamb is fully consistent with the fact that FC1-expressing egg chambers, in comparison to FC2-expressing egg chambers, are less efficient for OA-induced follicle rupture, but fully competent to respond to ionomycin-induced follicle rupture ([Figures 4D, H](#fig4){ref-type="fig"}, [6D and H](#fig6){ref-type="fig"}). The orchestrated upregulation of Mmp2 and Oamb, and possibly other components in the OA/Oamb-Ca^2+^-Mmp2 pathway, by Hnt makes the final stage-14C egg chambers fully competent for ovulation. Components in the ecdysteroid signaling pathway, including the enzyme Shd for steroid production and Ecdysone receptor (EcR), also changes its expression pattern from stage-13 to stage-14 ([@bib22]). It is unknown whether Hnt is also responsible for such changes; however, it is unlikely that ecdysteroid signaling upregulates Hnt in stage-14 follicle cells, because ecdysteroid signaling does not affect Mmp2 and Oamb expression ([@bib22]). Hnt is upregulated in follicle cells from stage 7 to stage 10A, which depends on Notch signaling ([@bib44]); however, Notch signaling is not active in stage-14 follicle cells and is unlikely to upregulate Hnt at this stage. Thus, the developmental signal for Hnt upregulation in stage14 and the transition from stage 13 to stage 14 is still unknown.

![A schematic cartoon summarizes the role of Hindsight in stage-14 follicle cells.\
Hnt expression is shown in red with different intensity indicating different expression level. Mmp2 expression is shown in green and Oamb expression is shown in blue. OA stands for octopamine.](elife-29887-fig9){#fig9}

Hindsight and its role in extracellular matrix homeostasis and epithelial integrity {#s3-2}
-----------------------------------------------------------------------------------

*Mmp2*, along with *Mmp1*, are the only genes in the fly genome encoding matrix metalloproteinase and are crucial for extracellular matrix homeostasis during normal development, wound repair, and cancer metastasis ([@bib34]; [@bib43]). Unlike Mmp1, whose expression is tightly regulated by Jun-related kinase (JNK) signaling ([@bib49]), regulation of Mmp2 expression is largely unknown. Our work clearly defines the role of Hnt in regulating Mmp2 expression and basement membrane remodeling during ovulation. Hnt directly binds to two adjacent Hnt-binding sequences in the regulatory region of *hnt* and *nervy* genes and attenuates their expression ([@bib28]). Such Hnt-binding motifs are not found in the gene region of *Mmp2 and Oamb*. Thus, Hnt may indirectly regulate Mmp2 expression in posterior follicle cells. In addition, other transcriptional regulators must exist to coordinate with Hnt to restrict Mmp2 expression to posterior follicle cells.

Hnt's role in regulating Mmp2 expression and extracellular matrix homeostasis may not be restricted to posterior follicle cells. It has been shown that Hnt has a general role in regulating epithelial integrity in multiple organ systems and developmental stages. During retinal morphogenesis, *hnt* mutant photoreceptor cells frequently delaminate from retinal epithelium and are unable to maintain their integrity ([@bib36]). In the tracheal system, *hnt* mutant tracheal epithelium disintegrate to form sacs and vesicles from collapsed dorsal trunk and branches ([@bib52]). During oogenesis, Hnt is essential for proper cell adhesion and collective cell migration in stage-9 egg chambers. Ectopic expression of Hnt in the cluster of border cells leads to dissociation of the border-cell cluster ([@bib26]). In addition, genetic modifier screens identify basement-membrane components Vkg and Laminin as Hnt's genetic interactors ([@bib51]). All of these studies suggest that Hnt plays general roles in regulating epithelial integrity and extracellular matrix homeostasis in multiple organ systems. It will be interesting to see whether the regulation of Mmp2 by Hnt also occurs in other Hnt-expressing or Mmp2-expressing tissues/organs.

Hindsight and human RREB-1 are functionally conserved in ovulation {#s3-3}
------------------------------------------------------------------

*Drosophila* Hnt and mammalian RREB-1 are functionally conserved in many aspects. Both *Drosophila* Hnt and mammalian RREB-1 are required for proper cell migration ([@bib26]). Human RREB-1 binds to similar DNA sequences in *Drosophila* salivary gland polytene chromosomes as Hnt and rescues the germ band retraction phenotype in *hnt* mutant embryos ([@bib28]). In addition, our current work shows that human RREB-1 is able to rescue *Oamb* and *Mmp2* expression in stage-14 follicle cells and OA-induced follicle rupture/ovulation phenotype in *hnt^RNAi^* females ([Figure 8](#fig8){ref-type="fig"}). The role of RREB-1 in mammalian ovulation has not been studied so far, however, RREB-1 is detected in granulosa cells in mouse ovaries by microarray analysis ([@bib14]). In addition, mammalian RREB-1 functions downstream of the Ras-MAPK signaling pathway in multiple occasions ([@bib19]; [@bib20]; [@bib30]; [@bib47]; [@bib54]), and the Ras-MAPK signaling pathway is involved in mammalian ovulation ([@bib14]). It is possible that RREB-1 may function in granulosa cells to regulate Mmp expression and ovulation downstream of Ras-MAPK pathway in mammals.

Materials and methods {#s4}
=====================

*Drosophila* genetics {#s4-1}
---------------------

Flies were reared on standard cornmeal and molasses food at 25°C, and all RNAi-mediated depletion experiments were performed at 29°C with *UAS-dcr2*. Two stage-14 follicle-cell specific Gal4 drivers from the Janelia Gal4 collection ([@bib35]) were used in this study: *R44E10-Gal4* (FC1) and *R47A04-Gal4* (FC2). The following RNAi lines were used: *UAS-hnt^RNAi1^* (V3788) and *UAS-hnt^RNAi2^* (V101325) from the Vienna *Drosophila* Resource Center; and *UAS-Mmp2^RNAi^* ([@bib49]). *UAS-Oamb.K3* ([@bib24]), *UAS-Timp* ([@bib33]), *hnt^EP55^* (a P-element insertion line containing UAS sequence in the promoter region of *hnt*; Bloomington Drosophila Stock Center, BDSC\# 5358), *UAS-RREB1::GFP* ([@bib28]) were used to overexpress *Oamb*, *Timp*, *Hnt*, and *RREB1*, respectively. *Oamb.K3* is the *Oamb* isoform expressed in wild-type stage-14 follicle cells ([@bib7]). *hnt^XE81^* and *hnt^EH704a^* are loss-of-function *hnt* alleles, while *hnt^peb^* (BDSC\# 80) is a temperature-sensitive *hnt* allele ([@bib51]). Animals bearing *hnt^peb^* were raised at room temperature, and newly emerged adult flies were shifted to the 29°C restrictive temperature. For generating flip-out actin-Gal4 clones ([@bib38]), *hsFLP;;act \<CD2\<Gal4,UAS-RFP/TM3, Sb* (derived from BDSC\# 30558) was used to cross to *hnt^EP55^* or *hnt^EP55^; UAS-hnt^RNAi^* and adult flies were heat shocked in a 37**°**C water bath for 45 min. *UASp-GFP::act79B; UAS-mCD8::GFP* was crossed to Gal4 lines and used to visualize Gal4 expression pattern. *UAS-RFP* was recombined to Gal4 drivers and used for isolating stage-14 egg chambers for *ex vivo* culture. *UAS-GCaMP5G* ([@bib1]) was used to visualize calcium responses in follicle cells (BDSC\# 42037). Protein trap lines *vkg::GFP^CC00791^* ([@bib3]) and *Mmp2::GFP* ([@bib6]) were used for Vkg and Mmp2 expression, respectively. Control flies for all experiments were prepared from crossing Gal4 drivers to Oregon-R.

Ovulation assays {#s4-2}
----------------

Egg laying and egg-laying time analyses were performed as previously described ([@bib7]; [@bib22]). Five virgin females (five-to-six days old with one day of wet yeast feeding) were placed with ten Oregon-R males in one bottle to lay eggs on grape juice-agar plates with a drop of wet yeast paste for two days in 29°C. After each day (22 hr in 29°C) of egg laying, grape juice-agar plates were removed and replaced with a new one. Typically, five bottles for each genotype are performed in each experiment. After egg laying, ovaries were dissected and mature follicles in female ovaries were counted. Virgin females were dissected before mating for a 'pre-egg laying' mature follicle count to ensure normal oogenesis occurred. The average number of eggs laid per female per day was used to calculate the average time to lay one egg, as described previously. The egg-laying time was further proportioned into the amount of time an egg spent in the ovary (ovulation time), in the oviduct (oviduct time), and in the uterus (uterus time) according to the distribution of females with eggs in their reproductive tract six hours after mating. For this assay, ten virgin females and fifteen males are mated in a vial with dry yeast at 29°C. Typically, two to three vials for each genotype were performed in each experiment. After a six-hour mating, the flies were frozen at −80°C for approximately four minutes, and then dissected to examine the location of an egg within the reproductive tract.

*Ex vivo* follicle rupture, gelatinase assay, and quantitative RT-PCR {#s4-3}
---------------------------------------------------------------------

The *ex vivo* follicle rupture assay was performed as described previously ([@bib7]). In brief, 5--6 day-old virgin females fed with wet yeast for 2--3 days were used to isolate stage-14 egg chambers in Grace's insect medium (Caisson Lab, Smithfield, UT). Within one hour, isolated mature follicles from \~10 females were separated into groups of \~30 egg chambers, then cultured in culture media (Grace's medium, 10% fetal bovine serum, and 1X penicillin/streptomycin) supplemented with 20 μM OA (Sigma, St. Louis, MO), or 5 μM ionomycin (Cayman Chemical Co., Ann Arbor, MI). All cultures were performed at 29°C, the same condition as flies were maintained, to enhance Gal4/UAS efficiency. One data point represents the percent of ruptured follicles per experimental group (\~30 egg chambers). Data were represented as mean percentage ± standard deviation (SD).

In situ zymography for detecting gelatinase activity was performed as previously reported with minor modifications ([@bib7]). 20--25 μg/mL of DQ-gelatin conjugated with fluorescein (Invitrogen, Eugene, OR) was added into the culture media with 20 μM OA for three hours. Mature follicles with posterior fluorescein signal were directly counted, and data represented as percent of follicles with posterior fluorescein signal. Follicles with lateral fluorescein signal, which is likely induced by damage during dissection, are not counted as Mmp2 activity, because Mmp2 is only expressed in posterior follicle cells ([@bib6]).

For quantitative RT-PCR, total RNA was extracted from 60 stage-14 egg chambers isolated from 10 flies using Direct-zol RNA MicroPrep Kit (Zymo Research, Orange, CA). cDNA synthesis, real-time PCR amplification and primers of *Oamb.K3* and *Mmp2* were described previously ([@bib22]). The data are presented as mean ± SEM from three biological replicates, except for *RREB-1* rescue experiment, in which one single biological experiment was presented.

Immunostaining and microscopy {#s4-4}
-----------------------------

Immunostaining was performed following a standard procedure, including ovary dissection, fixation in 4% EM-grade paraformaldehyde for 15 min, blocking in PBTG (PBS + 0.2% Triton + 0.5% BSA + 2% normal goat serum), and primary and secondary antibody staining diluted in PBTG. For *vkg::GFP* analysis, stage-14 egg chambers were first isolated from ovaries in cold Grace's medium before fixation. Mouse anti-Hnt (1:75; Developmental Study Hybridoma Bank), mouse anti-GFP (1:2000; Invitrogen), rabbit anti-GFP (1:4000; Invitrogen), and rabbit anti-RFP (1:1000; MBL international) were used as primary antibodies, and Alexa 488, 546, and 633 goat anti-mouse and goat anti-rabbit (1:1000, Invitrogen) were used as secondary antibodies. Images were acquired using a Leica TCS SP8 confocal microscope or Leica MZ10F fluorescent stereoscope with a sCOMS camera (PCO.Edge), and assembled using Photoshop software (Adobe Inc., Mountain View, CA) and ImageJ.

To visualize calcium response to ionomycin and octopamine, egg chambers expressing GCaMP5G and *hnt^RNAi^* were isolated into an imaging chamber. Images were acquired on a Zeiss Axio Zoom microscope at 0.2 FPS, and 10 μL of ionomycin or octopamine were added to the solution after frame five to a final concentration of 5 μM or 20 μM, respectively. A ROI in the center of the main-body follicle cells was selected and the integrated intensity was measured. F0 was defined as the average baseline intensity (first five frames), and ΔF/F0 is reported.

Statistical analysis {#s4-5}
--------------------

Statistical tests were performed using Prism 7 (GraphPad, San Diego, CA). For comparison of more than two means, one-way ANOVA with *post hoc* Fisher's Least Significant Difference test was used. For comparison of distribution, Chi square test was used except in [Figure 3D and H](#fig3){ref-type="fig"}, where Fisher's exact test was used. In addition, Z-score test was used for egg-laying time analysis in [Figure 3K--L](#fig3){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000002National Institutes of Health R01-HD086175 to Jianjun Sun.

-   http://dx.doi.org/10.13039/100000865Bill and Melinda Gates Foundation OPP1160858 to Jianjun Sun.

-   http://dx.doi.org/10.13039/100007710University of Connecticut Startup to Jianjun Sun.

We are thankful to Drs. Howard Lipshitz, Bruce Reed, Allan Spradling, Dirk Bohmann, Kyung-An Han, Andrea Page-McCaw, and Wu-Min Deng for sharing fly lines, the Bloomington Drosophila Stock Center and the Vienna Drosophila Stock Center for fly stocks, and the DHSB for antibodies. We are very grateful to Virge Kask at UConn Scientific Illustration Office for providing the illustration of *Drosophila* ovulation process, to the Conover, LoTurco, and Kanadia labs for sharing reagents and microscopes. We thank Drs. John Peluso and Joseph LoTurco as well as the anonymous reviewers for discussion and comments regarding the manuscript; and are grateful for Elizabeth Knapp and Wei Shen for technical support. Leica SP8 confocal microscope is supported by a NIH award (S10OD016435) to Akiko Nishiyama. JS is supported by the University of Connecticut Start-up fund, NIH/National Institute of Child Health and Human Development Grant R01-HD086175, and Bill and Melinda Gates Foundation.

Additional information {#s5}
======================

No competing interests declared.

Formal analysis, Investigation, Writing---original draft, Writing---review and editing.

Formal analysis, Investigation, Writing---review and editing.

Conceptualization, Formal analysis, Supervision, Funding acquisition, Project administration, Writing---review and editing.

Additional files {#s6}
================

10.7554/eLife.29887.027

###### The egg laying, egg distribution within the reproductive tract, and egg-laying time of females with various genotypes.

10.7554/eLife.29887.028

10.7554/eLife.29887.030

Decision letter

Yamashita

Yukiko M

Reviewing Editor

University of Michigan, Ann Arbor, HHMI

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Zinc-finger transcription factor Hindsight regulates ovulation competency of *Drosophila* follicles\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Marianne Bronner as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The manuscript \"Zinc-finger transcription factor Hindsight regulates ovulation competency of *Drosophila* follicles\"*eLife* by Deady, Li, and Sun is a thoroughly conducted study of what is possibly a conserved mechanism regarding the release of mature oocytes from the ovary. The present study builds on previous work and explores the regulation of oocyte competency in the *Drosophila* system. The submitted manuscript establishes that the expression of hindsight (hnt), the *Drosophila* ortholog of mammalian RREB-1, is required for this process. The manuscript is well written and the results are, for the most part, clearly presented.

Using follicle cell-specific GAL4 drivers as well as the morphology of nurse cell degeneration, the authors report that developing stage 14 egg chambers show strong hnt expression in follicle cells in a highly dynamic pattern. Stage 14 egg chambers are subdivided into 14A, 14B, and 14C stages and, stage 14B is shown to have the highest level of hnt expression. RNAi mediated knockdown of Hnt in stage 14 egg chambers is shown to result in ovulation defects and not oogenesis defects. These defects are demonstrated as being associated with reduced Mmp2 activity using a variety of assays. The hnt-knockdown phenotypes are corroborated by expression of the Mmp2 inhibitor Timp as well as Mmp2 RNAi mediated knockdown. Using an ex vivo assay, hnt-knockdown stage 14 egg chambers were found to be unresponsive to treatment with the Ca^2+^ ionophore ionomycin. Later stage, weaker hnt-knockdown egg chambers were responsive to ionomycin but were not responsive to the OA ligand for Oamb, which was previously known to be required for ovulation. The authors go on to show that reduced hnt expression results in reduced *Mmp2* and Oamb expression, and correctly state that this is not necessarily a direct relationship. Based on RT-PCR the authors show that hnt likely functions to up-regulate the transcription of Mmp2 and Oamb. It is suggested that RNAi mediated hnt knockdown can be rescued by co-expression of human RREB1-GFP.

Overall, this work is sound and is certainly of great interest to *Drosophila* oogenesis specialists. The extent to which this work would be of broader interest relates to the final rescue experiment, and it is here we feel further experiments would be required to support and validate the idea of a conserved function of hnt in ovulation.

Essential revisions:

Although most of the experiments are conducted in a rigorous manner, supporting their conclusions, weaknesses revolve around the fact that the validation of the RNAi-based method is not sufficient to fully support their conclusions. First, the data in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} show that knockdown is quite incomplete. Thus, additional validation that the phenotypes are indeed caused by hnt knockdown is required.

The *UAS-RREB-1* rescue experiment should be controlled for possible GAL4 / UAS \"competition\". This key experiment shows that there is a rescue of the hnt RNAi mediated knockdown phenotype by co-expression of *UAS-RREB-1::GFP*. I believe that it is possible that the rescue effect could be due to reduced efficiency of the RNAi knockdown, possibly through a non-specific effect such as less effective induction of UAS-hnt-RNAi expression due to the presence of the additional UAS responder element of *UAS-RREB-1::GFP*. (A possible titration effect of having additional UAS sequences available for the GAL4.) To control for this possibility of \"GAL4 competition\", a control experiment should be performed with a UAS-GFP in place of *UAS-RREB-1::GFP*. The level of expression of the UAS-GFP should be comparable to the *UAS-RREB-1::GFP*.

Does hnt-overexpression resemble RREB-1 expression? It would be informative to show if there is a phenotype associated with hnt over-expression (using UAS-hnt, UAS-GFP-Hnt, EP55, or P^GSV1^GS1018) in stage 14 follicle cells. Or if not over-expressed per se, is there a consequence to a prematurely high level of hnt expression, or maintenance of a high level of expression, in stage 14C -- and could this address whether the down-regulation of hnt expression in 14C stage is functionally significant? I.e. Is hnt over-expression sufficient for the premature rupture phenotype and/or upregulation of *Mmp2* and Oamb? Would such a phenotype resemble UAS-RREB1 expression, for example? These are fairly achievable experiments and their omission from this study seems puzzling to me.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"The zinc-finger transcription factor Hindsight regulates ovulation competency of *Drosophila* follicles\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Marianne Bronner (Senior editor), a Reviewing editor, and one reviewer.

The manuscript has been improved but there are some remaining issues, described in the review attached below, that need to be addressed before acceptance. These remaining issues are minor and can be addressed easily, so we anticipate to be able to accept your manuscript without further review upon revision. If you choose not to do the requested experiment, please provide an explanation in your response letter.

Reviewer \#2:

I have gone through the revised manuscript, \" The zinc-finger transcription factor Hindsight regulates ovulation competency of *Drosophila* follicles\"*eLife* by Deady, Li, and Sun.

I believe the authors have made clarifications and explanations to my satisfaction. It is an interesting story -- and the investigations of ovulation and follicle cell rupture as a conserved mechanism is of general interest to the field of developmental biology.

I believe that much of the difficulty relates to the subtly with which hnt depletion or expression can affect the phenotype during the relatively short time window of stage 14 egg chambers.

I was initially concerned that the RREB-1 rescue of UAS-hnt-RNAi might not be specific. The authors did address my concerns regarding UAS-titration effects.

The authors spend a fair amount of time addressing the issue of using GAL4 mediated co-expression of UAS-hnt-RNAi and UAS-hnt, presumably to demonstrate that the UAS-hnt-RNAi phenotype is specific to hnt depletion. I\'m not sure if these arguments, since the experiments were not effective, add anything to the manuscript other than some confusion.

What was much more convincing in my mind was the demonstration of ovulation defects using the temperature sensitive allele *hnt^peb^* -- which the authors call hnt^1^, as shown in the supplement to [Figure 4](#fig4){ref-type="fig"}. In the follicle cell rupture, both *hnt^peb^/hnt^XE81^* and *hnt^peb^/hnt^EH704a^* were reduced to below 30%, where FC2 controls in [Figure 4H](#fig4){ref-type="fig"} show \~80%.

Two questions come to mind:first,is *hnt^peb^* /+ control (\~ 50%) showing a dosage effect compared to + /+ control (\~80%)?;

and second,can the loss-of-function phenotype of *hnt^peb^/hnt^XE81^* and *hnt^peb^* /*hnt^EH704a^* be rescued by FC1 or FC2 GAL4 expression of *UAS-RREB-1*?

This latter experiment would completely and definitively address any concerns regarding effectiveness of RNAi depletion phenotypes and their rescue by UAS-RREB1.

Since the rescue of the knockdown is pivotal to a conserved function, I would really like to see inclusion of this experiment. It should only take a couple of fly generations to get the GAL4 + UAS lines into the *hnt^peb^/hnt^XE81^* and *hnt^peb^/hnt^EH704a^* backgrounds, and the assay is well established in the lab. I think it will strengthen the rescue results.

Also, is there any evidence that RREB-1 is expressed in the mammalian ovary? Is it possible to find out somehow? (Such as some high throughput data somewhere?) If so, then it would certainly strengthen the conserved function in ovulation. But if it is not? Then...?

10.7554/eLife.29887.031

Author response

> Essential revisions:
>
> Although most of the experiments are conducted in a rigorous manner, supporting their conclusions, weaknesses revolve around the fact that the validation of the RNAi-based method is not sufficient to fully support their conclusions. First, the data in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} show that knockdown is quite incomplete. Thus, additional validation that the phenotypes are indeed caused by hnt knockdown is required.

In this study, we have used two independent *hnt^RNAi^* lines, which are targeting non-overlapping regions of *hnt* mRNA (*hnt^RNAi1^* targeting nucleotide 4864-5206 and *hnt^RNAi2^* targeting nucleotide 1787-2077), to demonstrate that both *hnt^RNAi^* lines cause similar ovulation phenotypes. Although both *RNAi* lines are predicted to have potential off-targets (*hnt^RNAi1^*: CG10597 and CG5119; *hnt^RNAi2^*: CG10228, CG12673, and CG7991), the only overlapping target between these two *hnt^RNAi^* lines is the *hnt* gene. These data strongly suggest that *hnt* is responsible for the ovulation defect. We have also tried to use *UAS-hnt^EP55^* to rescue the defect of *hnt^RNAi^* females. Despite using the Gal4/UAS system to overexpress *hnt* mRNA, unfortunately Hnt protein was still depleted by RNAi and not restored to normal level, and thus no rescue was observed (we added this result to new [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). In contrast, mammalian homolog RREB-1, which will not be targeted by *hnt^RNAi^*, is able to fully rescue the follicle rupture defect caused by *hnt* knockdown ([Figure 8](#fig8){ref-type="fig"}). This data also strongly support our conclusion that rupture defect in RNAi-based method is indeed caused by *hnt* knockdown, not peculiar RNAi off-target effect. Furthermore, we showed that mature follicles from *hnt* transheterozygous mutant females with a temperature-sensitive *hnt* allele also showed defect in OA-induced follicle rupture ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). All these genetic evidence support our conclusion that *hnt* is the gene required for follicle rupture/ovulation.

Reviewers also pointed out that *hnt^RNAi^* knockdown is quite incomplete. It is true that *hnt* knockdown is incomplete, which is largely due to the late expression of Gal4 driver (both are in stage-14 egg chambers) and short developmental time (stage 14 only lasts for a little more than two hours and it only takes six hours to develop from stage 10 to stage 14). However, *hnt* is strongly depleted whenever Gal4 driver has high expression. For example, FC1 Gal4 is efficient to deplete *hnt* in stage 14B and stage 14C ([Figure 3D](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1H](#fig3s1){ref-type="fig"}), while FC2 Gal4 is efficient to deplete *hnt* in stage 14C ([Figure 3H](#fig3){ref-type="fig"}). The incomplete depletion of *hnt* is also quite consistent with incomplete block of ovulation in *hnt^RNAi^* females. Thus, we strongly believe the ovulation defect is indeed caused by *hnt* depletion.

> The UAS-RREB-1 rescue experiment should be controlled for possible GAL4 / UAS \"competition\". This key experiment shows that there is a rescue of the hnt RNAi mediated knockdown phenotype by co-expression of UAS-RREB-1::GFP. I believe that it is possible that the rescue effect could be due to reduced efficiency of the RNAi knockdown, possibly through a non-specific effect such as less effective induction of UAS-hnt-RNAi expression due to the presence of the additional UAS responder element of UAS-RREB-1::GFP. (A possible titration effect of having additional UAS sequences available for the GAL4.) To control for this possibility of \"GAL4 competition\", a control experiment should be performed with a UAS-GFP in place of UAS-RREB-1::GFP. The level of expression of the UAS-GFP should be comparable to the UAS-RREB-1::GFP.

We do not believe that *UAS-RREB1::GFP* rescue effect is due to a titration effect of Gal4 by having an additional UAS sequence in this rescue experiment, because *UAS-Oamb,* which also contains an additional UAS sequence, could not rescue the follicle rupture defect ([Figure 7C](#fig7){ref-type="fig"}), nor did *UAS-hnt^EP55^* ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}). In addition, we performed the experiment as reviewers suggested to use a *UAS-GFP* to do the rescue experiment, and it didn't show any rescue effect as well ([Figure 8---figure supplement 3](#fig8s3){ref-type="fig"}).

> Does hnt-overexpression resemble RREB-1 expression? It would be informative to show if there is a phenotype associated with hnt over-expression (using UAS-hnt, UAS-GFP-Hnt, EP55, or P{GSV1}GS1018) in stage 14 follicle cells. Or if not over-expressed per se, is there a consequence to a prematurely high level of hnt expression, or maintenance of a high level of expression, in stage 14C -- and could this address whether the down-regulation of hnt expression in 14C stage is functionally significant? I.e. Is hnt over-expression sufficient for the premature rupture phenotype and/or upregulation of Mmp2 and Oamb? Would such a phenotype resemble UAS-RREB1 expression, for example? These are fairly achievable experiments and their omission from this study seems puzzling to me.

We agree with reviewers that these are excellent experiments to carry out. We used *hnt^EP55^* line to perform the rescue and overexpression experiments as *RREB1::GFP* line. Unfortunately, *hnt^RNAi^* lines are strong enough to block any overexpressed *hnt* mRNA through Gal4/UAS system and leave Hnt protein still depleted in rescue experiments, and no rescue effect was observed. The strong depletion of Hnt protein by *hnt^RNAi^* when *hnt^EP55^* was included was further validated using a flip-out actin-Gal4 system. These data are now included in [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}. In addition, we also observed slight increase of follicle rupture when *hnt* is overexpressed using FC1 Gal4, very similar with overexpression of *RREB1::GFP* with FC1 Gal4. This is consistent with our hypothesis that Hnt functions as competency factor to regulate follicle maturation. The phenotype is weak, which is likely due to the fact that FC1 Gal4 only starts to be expressed in stage 14, when endogenous Hnt already starts expression. It would be ideal to have a Gal4 driver expressed in stage 13 and use such Gal4 driver to overexpress *hnt*, but unfortunately, we are not aware of the existence of this type of Gal4 line. Furthermore, we tried to maintain high *hnt* expression in stage-14C using FC2 Gal4, it caused slight reduction of follicle rupture but no egg-laying defect. Thus, we didn't make any conclusion to avoid over-interpreting the data. We also performed similar experiments with UAS-Hnt::GFP lines from Dr. Howard Lipshitz's lab and they showed the same result as *hnt^EP55^* line.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> Reviewer \#2:
>
> \[...\] Two questions come to mind:first,is hnt^peb^/+ control (\~ 50%) showing a dosage effect compared to + /+ control (\~80%)?;

We have repeated this experiment multiple times with two different researchers. Both came out the same result that *hnt^peb^/+; FC2\>RFP/+* follicles showed \~50% rupture rate instead of \~80% in wild-type control. Therefore, we think it is possible that *hnt^peb^/+* causes a dosage effect. This dose effect may not just caused by *hnt* in the mature follicle cells, but also from other tissues expressing *hnt* (see response to question 2). Alternatively, *hnt^peb^* may behave as a dominant negative allele since the nature of the temperature sensitivity is unknown.

> and second,can the loss-of-function phenotype of hntpeb /hntXE81 and hntpeb /hntEH704a be rescued by FC1 or FC2 GAL4 expression of UAS-RREB-1? This latter experiment would completely and definitively address any concerns regarding effectiveness of RNAi depletion phenotypes and their rescue by UAS-RREB1. Since the rescue of the knockdown is pivotal to a conserved function, I would really like to see inclusion of this experiment. It should only take a couple of fly generations to get the GAL4 + UAS lines into the hntpeb /hntXE81 and hntpeb /hntEH704a backgrounds, and the assay is well established in the lab. I think it will strengthen the rescue results.

We do not believe that FC1 or FC2 driving *UAS-RREB-1* expression will rescue the *hnt* loss-of-function phenotype for the following reasons: Hnt is not only expressed in stage-14 follicle cells, but also expressed in follicle cells of stage 7-stage10B, which is essential for follicle cell differentiation according to my previous study (Sun and Deng, 2007). Although no morphological defect was observed in *hnt^peb/XE81^*and *hnt^peb/EH704a^*mature follicles, we cannot exclude that subtle defect in early development may contribute to the follicle rupture defect. That's why we used RNAi to bypass earlier Hnt function in our initial experiments. In addition, Hnt is also expressed in the midgut enterocytes and secretory cells in the female reproductive tract. The latter has been demonstrated to regulate ovulation as well (Sun and Spradling, 2013). Hnt may also function in the secretory cells in the female reproductive tract to regulate follicle rupture in addition to its role in the mature follicle cells. This is supported by our recent finding that another transcription factor is functioning in both secretory cells and mature follicle cells to regulate follicle rupture (Knapp and Sun, manuscript in preparation; this story is also going to be presented in the Annual *Drosophila* Research Conference in April 2018). We are interested in investigating the role of Hnt in serectory cells, but this is out of the scope of this study. Therefore, we do not believe this experiment will work. Even this will work, which will take another two months with several generations of crosses, it would not add any new findings to our current conclusion.

> Also, is there any evidence that RREB-1 is expressed in the mammalian ovary? Is it possible to find out somehow? (Such as some high throughput data somewhere?) If so, then it would certainly strengthen the conserved function in ovulation. But if it is not? Then...?

I am sure there're high throughput data available to support that RREB-1 is expressed in mammalian ovary, but many of those data are not conclusive and need further validation. We are interested in this question and our preliminary data had showed that RREB-1 is expressed in follicles in LH-dependent manner. We are in the process of generating RREB-1 conditional knockout mouse to test its role in mammals. This project is out of the scope of this current study.
